---  
layout: startup_page  
title: "FogPharma"  
id: "fogpharma.com"  
permalink: "/fogpharmafogpharma.com03012024/"  
website: "https://www.fogpharma.com"  
funding_round: "Series E"  
funding_amount: "$145M"  
investors: "Nextech Invest, RA Capital Management, Rock Springs Capital, General Catalyst, Marshall Wace, Samsara Biocapital, Foresite Capital, Symbiosis, Catalio Capital Management, Sixty Degree Capital, Alex Gorsky, ARCH Venture Partners, Fidelity Management & Research Company, GV, Cormorant Asset Management, funds and accounts advised by T. Rowe Price Associates, Inc., Farallon Capital Management, venBio Partners, Invus, Milky Way Investments"  
about: "FogPharma is a clinical-stage biopharmaceutical company developing Helicon™ peptide therapies to target intracellular disease drivers previously inaccessible to traditional medicines. Its lead candidate, FOG-001, is a β-catenin inhibitor in Phase 1/2 trials for solid tumors, addressing a significant unmet need in oncology. The company leverages AI and computational physics in its drug discovery process."  
markets: "Biotechnology, Pharmaceuticals, Oncology, Health Care, Life Science, Precision Medicine"  
hq: "Cambridge, Massachusetts, United States"  
founded_year: "2015"  
linkedin: "https://www.linkedin.com/company/fog-pharmaceuticals/"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/fog-pharmaceuticals"  
pitchbook: "https://pitchbook.com/profiles/company/160876-99"  

date_display: "01-Mar-2024"  
date: "2024-03-01"

# SEO Optimization  
meta_title: "FogPharma - Series E Funding ($145M)"  
meta_description: "FogPharma, FogPharma is a clinical-stage biopharmaceutical company developing Helicon™ peptide therapies to target intracellular disease drivers previously inacc..."  
meta_keywords: "FogPharma, Biotechnology, Pharmaceuticals, Oncology, Health Care, Life Science, Precision Medicine, Series E funding"  
canonical_url: "https://startup.projectstartups.com/fogpharmafogpharma.com03012024/"  
---